Discovery of a novel lead structure for anti-malarials
- 31 March 2001
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 9 (3) , 785-792
- https://doi.org/10.1016/s0968-0896(00)00296-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: structural requirements of the central moiety for farnesyltransferase inhibitory activityBioorganic & Medicinal Chemistry, 2000
- Design, synthesis and early structure–activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrateBioorganic & Medicinal Chemistry, 2000
- Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitorsEuropean Journal of Medicinal Chemistry, 2000
- Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central GroupPharmacy and Pharmacology Communications, 2000
- Design, Synthesis, and Evaluation of Novel Modular Bisubstrate Analogue Inhibitors of FarnesyltransferaseAngewandte Chemie International Edition in English, 1999
- Chapter 33. Malaria: A Third World Disease in Need of First World Drug DevelopmentPublished by Elsevier ,1999
- Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution techniqueAntimicrobial Agents and Chemotherapy, 1979
- Human Malaria Parasites in Continuous CultureScience, 1976